Back
J&J Snack Foods 10K Form
Buy
57
JJSF
J&J Snack Foods
Last Price:
164.07
Seasonality Move:
5.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | JJSF/J&J Snack Foods Quarterly |
2024-02-07 | 10Q | JJSF/J&J Snack Foods Quarterly |
2023-08-03 | 10Q | JJSF/J&J Snack Foods Quarterly |
2023-05-04 | 10Q | JJSF/J&J Snack Foods Quarterly |
2023-02-02 | 10Q | JJSF/J&J Snack Foods Quarterly |
2022-08-04 | 10Q | JJSF/J&J Snack Foods Quarterly |
Receive JJSF News And Ratings
See the #1 stock for the next 7 days that we like better than JJSF
JJSF Financial Statistics
Sales & Book Value
Annual Sales: | $1.56B |
---|---|
Cash Flow: | $-3.95M |
Price / Cash Flow: | 30.01 |
Annual Sales: | $47.23 |
Price / Book: | 3.48 |
Profitability
EPS (TTM): | 4.44000 |
---|---|
Net Income (TTM): | $86.01M |
Gross Margin: | $469.87M |
Return on Equity: | 9.59% |
Return on Assets: | 6.68% |
J&J Snack Foods Earnings Forecast
Key J&J Snack Foods Financial Ratios
- The Gross Profit Margin over the past 40 years for JJSF is 30.14%.
- The Selling, General & Administrative Expenses for JJSF have been equal to 23.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 6.02% of Operating Income.
- The Net Earning history of JJSF is 5.06% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 29 years.
J&J Snack Foods Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Food Products |
Sector: | Consumer Staples |
Current Symbol: | JJSF |
CUSIP: | 466032 |
Website: | jjsnack.com |
Debt
Debt-to-Equity Ratio: | 0.02 |
---|---|
Current Ratio: | 2.41 |
Quick Ratio: | 1.27 |
Price-to-Earnings
Trailing P/E Ratio: | 40.23 |
---|---|
Forward P/E Ratio: | 27.2 |
JJSF Technical Analysis vs Fundamental Analysis
Buy
57
J&J Snack Foods (JJSF)
is a Buy
Is J&J Snack Foods a Buy or a Sell?
-
J&J Snack Foods stock is rated a Buy
The current J&J Snack Foods [JJSF] share price is $164.15. The Score for JJSF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.